Search

Moleti, Mariacarla, Filiberto Mattina, Ignazio Salamone, Maria Antonia Violi, Carmelo Nucera, Sergio Baldari, Maria Grazia Lo Schiavo, Concetto Regalbuto, Francesco Trimarchi, and Francesco Vermiglio. 2003. “Effects of Thyroidectomy Alone or Followed by Radioiodine Ablation of Thyroid Remnants on the Outcome of Graves’ Ophthalmopathy.”. Thyroid : Official Journal of the American Thyroid Association 13 (7): 653-8.

Prete, Alessandro, Agnes S Lo, Peter M Sadow, Swati S Bhasin, Zeus A Antonello, Danica M Vodopivec, Soumya Ullas, et al. 2018. “Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis.”. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 24 (23): 6078-97.

Duquette, Mark, Peter M Sadow, Amjad Husain, Jennifer N Sims, Zeus A Antonello, Andrew H Fischer, Chen Song, et al. 2015. “Metastasis-Associated MCL1 and P16 Copy Number Alterations Dictate Resistance to Vemurafenib in a BRAFV600E Patient-Derived Papillary Thyroid Carcinoma Preclinical Model.”. Oncotarget 6 (40): 42445-67.

Husain, Amjad, Nina Hu, Peter M Sadow, and Carmelo Nucera. 2016. “Expression of Angiogenic Switch, Cachexia and Inflammation Factors at the Crossroad in Undifferentiated Thyroid Carcinoma With BRAF(V600E).”. Cancer Letters 380 (2): 577-85.

Mekel, Michal, Carmelo Nucera, Richard A Hodin, and Sareh Parangi. 2010. “Surgical Implications of B-RafV600E Mutation in Fine-Needle Aspiration of Thyroid Nodules.”. American Journal of Surgery 200 (1): 136-43.

Nucera, Carmelo, Alessandro Porrello, Zeus Andrea Antonello, Michal Mekel, Matthew A Nehs, Thomas J Giordano, Damien Gerald, et al. 2010. “B-Raf(V600E) and Thrombospondin-1 Promote Thyroid Cancer Progression.”. Proceedings of the National Academy of Sciences of the United States of America 107 (23): 10649-54.

Beroukhim, Rameen, Craig H Mermel, Dale Porter, Guo Wei, Soumya Raychaudhuri, Jerry Donovan, Jordi Barretina, et al. 2010. “The Landscape of Somatic Copy-Number Alteration across Human Cancers.”. Nature 463 (7283): 899-905.

Iesato, Asumi, and Carmelo Nucera. 2021. “Tumor Microenvironment-Associated Pericyte Populations May Impact Therapeutic Response in Thyroid Cancer.”. Advances in Experimental Medicine and Biology 1329: 253-69.

Valvo, Veronica, Asumi Iesato, Taylor R Kavanagh, Carmen Priolo, Zsuzsanna Zsengeller, Alfredo Pontecorvi, Isaac E Stillman, Suzanne D Burke, Xiaowen Liu, and Carmelo Nucera. 2021. “Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in BRAFV600E Papillary Thyroid Carcinoma.”. Thyroid : Official Journal of the American Thyroid Association 31 (9): 1335-58.

Nucera, Carmelo. 2019. “A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer.”. Oncotarget 10 (7): 686-87.